The Biopharmaceutical Excipient Manufacturing Market Size is valued at 2.73 Billion in 2024 and is predicted to reach 4.38 Billion by the year 2034 at a 5.0% CAGR during the forecast period for 2025-2034.
Key Industry Insights & Findings from the Report:
Excipients are carrier agents beneficial for biopharmaceutical formulations. They offer efficient binding of ingredients, increase drug stability in the dosage form and modify the solubility of API. Excipients are inert, reproducible substances created from minerals, sugar, wheat, corn, and other such ingredients. They can reduce operating costs, enhance productivity, and improve product quality.
Major driving factors of the biopharmaceutical excipient manufacturing market are the surging applications of excipients, increasing initiatives by market players to develop excipients for innovating high-quality drugs, growing focus on the development of novel drugs, rising cases of chronic diseases, increasing use of lipid and sucrose-based excipients, advances in the field of pharmaceutical manufacturing, and the increasing R&D activities in the pharmaceutical industries. The increasing COVID cases have increased the drug manufacturing burden of biopharmaceutical companies to treat the affected patients. Hence, companies are rising their focus on fast drug development. Excipients are effective and efficient in enhancing the manufacturing process for biopharmaceuticals.
Therefore, the demand for biopharmaceutical excipients is surging to develop innovative and stabilized drugs, thereby creating significant growth opportunities during the forecast period. However, complexities associated with drug manufacturing along with the requirement of high capital investments may hinder the market growth during the forecast period.
The biopharmaceutical excipient manufacturing market is segmented based on the type of biologics, Product Type, scale of operation, and region. The type of biologics segment comprises antibodies, vaccines, cell therapies, and other biologics. The product type market is categorized into carbohydrates, solubilizers/surfactants, polyols, and specility excipients. The carbohydrates segment is expected to dominate this market in the forthcoming years due to the rising use of carbohydrate-based excipient products such as sucrose and starch in drug formulations. By scale of operation, the market is classified into preclinical, clinical, and commercial. Region-wise, the market is studied across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Asia-Pacific is estimated to be the rapidly growing regional market in the next few years due to the increasing incidences of chronic diseases, rising government funding for healthcare, and the growing demand for drugs. India and China are the emerging countries of this market
The Biopharmaceutical Excipient Manufacturing Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 2.73 Bn |
|
Revenue Forecast In 2034 |
USD 4.38 Bn |
|
Growth Rate CAGR |
CAGR of 5.0% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By Type of Biologics, By Scale Of Operation |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
ABITEC Corporation, Aceto, Angus Chemical, Apothecon, Ashland Global, Associated British Foods plc, Avantor, BASF SE, BioSpectra, BOC Sciences, C.G. Group, Clariant, Colorcon, Croda International Plc, DFE Pharma, DOW, Eastman Chemical, Evonik Industries AG, IMCD N.V., Innophos, Invitria, J. RETTENMAIER & SÖHNE GmbH + Co KG, Kirsch Pharma, Meggle Pharma, Merck KGaA, Novo Nordisk, Pfanstiehl, Inc., Pharmonix, Roquette Freres, Shin-Etsu Chemical, Sigachi Industries Limited, Signet Excipients Pvt. Ltd (IMCD), Spectrum Chemical Manufacturing Corp., SPI Pharma, Stepan Company, Tereos, The Lubrizol, Wacker Chemie, |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Biopharmaceutical Excipient Manufacturing Market Snapshot
Chapter 4. Global Biopharmaceutical Excipient Manufacturing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Type Of Biologics, Estimates & Trend Analysis
5.1. By Type Of Biologics, & Market Share, 2024 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type Of Biologics:
5.2.1. Antibodies
5.2.2. Vaccines
5.2.3. Cell Therapies
5.2.4. Other Biologics
Chapter 6. Market Segmentation 2: By Product Type Estimates & Trend Analysis
6.1. By Product Type & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Product Type:
6.2.1. Solubilizers & Surfactants/Emulsifiers
6.2.1.1. Triglycerides
6.2.1.2. Esters
6.2.1.3. Others (Sodium Cocoyl Glutamate, Glyceryl Caprylate; Citric Acid; Polyglyceryl-6 Oleate; Sodium Surfactin)
6.2.2. Polyols
6.2.2.1. Mannitol
6.2.2.2. Sorbitol
6.2.2.3. Others (Lactitol, Isomalt, xylitol)
6.2.3. Carbohydrates
6.2.3.1. Sucrose
6.2.3.2. Dextrose
6.2.3.3. Starch
6.2.3.4. Others (Lactose, Cellolose, Fructose)
6.2.4. Specialty Excipients
Chapter 7. Market Segmentation 3: By Scale Of Operations Estimates & Trend Analysis
7.1. By Scale of Operation & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Scale of Operation:
7.2.1. Research
7.2.2. Commercial
Chapter 8. Biopharmaceutical Excipient Manufacturing Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) estimates and forecasts By Type Of Biologics, 2021-2034
8.1.2. North America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) estimates and forecasts By Product Type, 2021-2034
8.1.3. North America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) estimates and forecasts By Scale of Operation, 2021-2034
8.1.4. North America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Type Of Biologics, 2021-2034
8.2.2. Europe Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Product Type, 2021-2034
8.2.3. Europe Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Scale of Operation, 2021-2034
8.2.4. Europe Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Type Of Biologics, 2021-2034
8.3.2. Asia Pacific Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Product Type, 2021-2034
8.3.3. Asia Pacific Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Scale of Operation, 2021-2034
8.3.4. Asia Pacific Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Type Of Biologics, (US$ Million) 2021-2034
8.4.2. Latin America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.4.3. Latin America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Scale of Operation, (US$ Million) 2021-2034
8.4.4. Latin America Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Type Of Biologics, (US$ Million) 2021-2034
8.5.2. Middle East & Africa Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Product Type, (US$ Million) 2021-2034
8.5.3. Middle East & Africa Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) By Scale of Operation, (US$ Million) 2021-2034
8.5.4. Middle East & Africa Biopharmaceutical Excipient Manufacturing Market revenue (US$ Million) by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. ABITEC Corporation
9.2.2. Aceto
9.2.3. Angus Chemical
9.2.4. Apothecon
9.2.5. Ashland Global
9.2.6. Associated British Foods plc
9.2.7. Avantor
9.2.8. BASF SE
9.2.9. BioSpectra
9.2.10. BOC Sciences
9.2.11. C.G. Group
9.2.12. Clariant
9.2.13. Colorcon
9.2.14. Croda International Plc
9.2.15. DFE Pharma
9.2.16. DOW
9.2.17. Eastman Chemical
9.2.18. Evonik Industries AG
9.2.19. IMCD N.V.
9.2.20. Innophos
9.2.21. Invitria
9.2.22. J. RETTENMAIER & SÖHNE GmbH + Co KG
9.2.23. Kirsch Pharma
9.2.24. Meggle Pharma
9.2.25. Merck KGaA
9.2.26. Novo Nordisk
9.2.27. Pfanstiehl, Inc.
9.2.28. Pharmonix
9.2.29. Roquette Freres
9.2.30. Shin-Etsu Chemical
9.2.31. Sigachi Industries Limited
9.2.32. Signet Excipients Pvt. Ltd (IMCD)
9.2.33. Spectrum Chemical Manufacturing Corp.
9.2.34. SPI Pharma
9.2.35. Stepan Company
9.2.36. Tereos
9.2.37. The Lubrizol
9.2.38. Wacker Chemie
9.2.39. Other Prominent Players
Global Biopharmaceutical Excipient Manufacturing Market, by Type of Biologics,
Global Biopharmaceutical Excipient Manufacturing Market, by Type of Product,
Global Biopharmaceutical Excipient Manufacturing Market, by By Scale of Operation,
Global Biopharmaceutical Excipient Manufacturing Market, by Region,
North America Biopharmaceutical Excipient Manufacturing Market, by Country,
Europe Biopharmaceutical Excipient Manufacturing Market, by Country,
Asia Pacific Biopharmaceutical Excipient Manufacturing Market, by Country,
Latin America Biopharmaceutical Excipient Manufacturing Market, by Country,
Middle East & Africa Biopharmaceutical Excipient Manufacturing Market, by Country,
Competitive Landscape
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
